CStone Pharmaceuticals
HKEX:2616

Watchlist Manager
CStone Pharmaceuticals Logo
CStone Pharmaceuticals
HKEX:2616
Watchlist
Price: 3.91 HKD -0.26% Market Closed
Market Cap: 5.3B HKD

Wall Street
Price Targets

Price Targets Summary
CStone Pharmaceuticals

Wall Street analysts forecast CStone Pharmaceuticals stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CStone Pharmaceuticals is 2.83 HKD with a low forecast of 2.8 HKD and a high forecast of 2.91 HKD.

Lowest
Price Target
2.8 HKD
28% Downside
Average
Price Target
2.83 HKD
28% Downside
Highest
Price Target
2.91 HKD
26% Downside
CStone Pharmaceuticals Competitors:
Price Targets
BRNS
Barinthus Biotherapeutics PLC
361% Upside
688278
Xiamen Amoytop Biotech Co Ltd
36% Upside
CSL
CSL Ltd
33% Upside
251120
Bio-FD&C Co Ltd
17% Upside
4593
Healios KK
8% Downside
BVXP
Bioventix PLC
67% Upside
002007
Hualan Biological Engineering Inc
21% Upside
2696
Shanghai Henlius Biotech Inc
22% Downside

Revenue
Forecast

Revenue Estimate
CStone Pharmaceuticals

The compound annual growth rate of CStone Pharmaceuticals's revenue for the next 3 years is 25%.

N/A
Past Growth
25%
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Operating Income
Forecast

Operating Income Estimate
CStone Pharmaceuticals

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
17%
Average Beat

Net Income
Forecast

Net Income Estimate
CStone Pharmaceuticals

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CStone Pharmaceuticals's stock price target?
Price Target
2.83 HKD

According to Wall Street analysts, the average 1-year price target for CStone Pharmaceuticals is 2.83 HKD with a low forecast of 2.8 HKD and a high forecast of 2.91 HKD.

What is CStone Pharmaceuticals's Revenue forecast?
Projected CAGR
25%

The compound annual growth rate of CStone Pharmaceuticals's revenue for the next 3 years is 25%.

Back to Top